Boehringer’s Trajenta launched in the UK
September 20, 2011Sales and Marketing Boehringer, Trajenta, diabetes
Boehringer Ingelheim has launched its new diabetes drug Trajenta in the UK, with a price tag to match its rival …
Teva makes commitment to Russian manufacturing facility
September 20, 2011Manufacturing and Production, Sales and Marketing Russia, Teva
Teva has joined a number of its peers in the pharmaceutical sector and announced plans to build a new manufacturing …
Intersex fish add to concerns about pharma wastewater
September 20, 2011Business Services, Manufacturing and Production Contamination, pharma manufacturing news
Researchers in France have discovered that wild fish living downstream from a pharmaceutical production plant making steroid drugs show serious …
Merck licences new MS drug
September 19, 2011Research and Development Cladribine, Merck KGaA, Merck Serono, PI-2301
Merck KGaA has in-licensed a new multiple sclerosis drug and aims to start it in phase II studies later this …
Alkermes and Elan Drug Technologies complete merger
September 19, 2011Manufacturing and Production Alkermes, Elan, pharma manufacturing news
The contract manufacturing and development unit of Irish drugmaker Elan has completed a near-$1 billion merger with drug delivery specialist …
Dr Arvind Hundal joins Zealand Pharma
September 19, 2011Sales and Marketing appointment, sales and marketing
Zealand Pharma has boosted its executive management team with the appointment of Dr Arvind Hundal as chief business officer. She …
ArcMedia appoints communications coaches
September 19, 2011Medical Communications, Sales and Marketing appointment, medical communications, sales and marketing
UK speaker training agency ArcMedia has appointed new communications consultants Linda Gummery and Charlotte Hume. Linda spent eight years leading …
Working Life: Graham Morris from BMS
September 19, 2011Sales and Marketing Working Life
Bristol-Myers Squibb’s CV/Metabolics business unit director Graham Morris on how his field is changing and the best, and worst, things …
Cancer Fund improving treatment access
September 19, 2011Sales and Marketing Cancer Drugs Fund, postcode prescribing
The Cancer Drugs Fund is dramatically improving access to new cancer medicines for patients in England – but its success …
Melanoma: new treatments and hopes
September 19, 2011Research and Development advanced melanoma, melanoma, skin cancer
It usually starts with a subtle change of colour or shape in an existing mole. But if left undiagnosed and …
Eliquis launched in the UK
September 19, 2011Sales and Marketing Eliquis, Pradaxa, VTE, Xarelto
Eliquis, the latest entrant to the competitive oral anticoagulant market, has been launched in the UK.Co-developed and co-marketed by Pfizer …
McLaren alliance to turbocharge GSK research
September 16, 2011Manufacturing and Production, Research and Development GSK, manufacturing and production news, pharma manufacturing news, research and development news
GlaxoSmithKline has turned to the engineering expertise of Formula 1 racing team McLaren in an innovative alliance designed to transform …
UK-funded science research must be made more accessible, says minister
September 16, 2011Medical Communications, Research and Development UK science
Research paid for by the UK taxpayer must be made more accessible to the public, researchers and other stake holders, …
Positive results for phase II malaria vaccine
September 16, 2011Research and Development malaria, malaria vaccine
Researchers in the US and West Africa believe they have identified the first effective blood-stage malaria vaccine, a development which …
Edelman appoints new head of digital health
September 16, 2011Medical Communications appointment, medical communications
Edelman has appointed Dave Pinnington as head of digital health for Europe to lead the development of the PR firm’s …
Firstlight launches new health offering
September 16, 2011Medical Communications Firstlight, medical communications news
London-based PR agency Firstlight has set up a new healthcare arm and appointed Pat Pearson to lead it. He is …
Merck’s COPD drug rejected by NICE
September 15, 2011Sales and Marketing Daxas, MSD, Merck & Co, NICE, roflumilast
NICE has not recommended Merck Co’s Daxas and has advised the firm to conduct a clinical trial in order to …
Designing clinical trials for the real world
September 15, 2011Research and Development clinical trials
A few years ago I was dealing with a big CRO which had been commissioned to run a pharmacokinetics (PK) …
Almirall promotes Alfredo Barón
September 15, 2011Sales and Marketing appointment, sales and marketing
Spanish pharma company Almirall has promoted Alfredo Barón to area director for Southern and Eastern Europe. He has been with the …
Fresh scrutiny for new diabetes drugs
September 15, 2011Sales and Marketing Byetta, GLP-1, Januvia, Merck, Novo Nordisk, Victoza, diabetes
Merck’s Januvia and Lilly’s Byetta face renewed safety questions this week as the European Association for the Study of Diabetes …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
